IBDEI2EU ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,40888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40888,1,3,0)
 ;;=3^Acute Upper Respiratory Infection,Unspec
 ;;^UTILITY(U,$J,358.3,40888,1,4,0)
 ;;=4^J06.9
 ;;^UTILITY(U,$J,358.3,40888,2)
 ;;=^5008143
 ;;^UTILITY(U,$J,358.3,40889,0)
 ;;=J33.9^^159^1995^19
 ;;^UTILITY(U,$J,358.3,40889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40889,1,3,0)
 ;;=3^Nasal Polyp,Unspec
 ;;^UTILITY(U,$J,358.3,40889,1,4,0)
 ;;=4^J33.9
 ;;^UTILITY(U,$J,358.3,40889,2)
 ;;=^5008208
 ;;^UTILITY(U,$J,358.3,40890,0)
 ;;=J32.0^^159^1995^15
 ;;^UTILITY(U,$J,358.3,40890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40890,1,3,0)
 ;;=3^Chronic Maxillary Sinusitis
 ;;^UTILITY(U,$J,358.3,40890,1,4,0)
 ;;=4^J32.0
 ;;^UTILITY(U,$J,358.3,40890,2)
 ;;=^24407
 ;;^UTILITY(U,$J,358.3,40891,0)
 ;;=J32.1^^159^1995^14
 ;;^UTILITY(U,$J,358.3,40891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40891,1,3,0)
 ;;=3^Chronic Frontal Sinusitis
 ;;^UTILITY(U,$J,358.3,40891,1,4,0)
 ;;=4^J32.1
 ;;^UTILITY(U,$J,358.3,40891,2)
 ;;=^24380
 ;;^UTILITY(U,$J,358.3,40892,0)
 ;;=J32.9^^159^1995^16
 ;;^UTILITY(U,$J,358.3,40892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40892,1,3,0)
 ;;=3^Chronic Sinusitis,Unspec
 ;;^UTILITY(U,$J,358.3,40892,1,4,0)
 ;;=4^J32.9
 ;;^UTILITY(U,$J,358.3,40892,2)
 ;;=^5008207
 ;;^UTILITY(U,$J,358.3,40893,0)
 ;;=J30.9^^159^1995^11
 ;;^UTILITY(U,$J,358.3,40893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40893,1,3,0)
 ;;=3^Allergic Rhinitis,Unspec
 ;;^UTILITY(U,$J,358.3,40893,1,4,0)
 ;;=4^J30.9
 ;;^UTILITY(U,$J,358.3,40893,2)
 ;;=^5008205
 ;;^UTILITY(U,$J,358.3,40894,0)
 ;;=J30.0^^159^1995^24
 ;;^UTILITY(U,$J,358.3,40894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40894,1,3,0)
 ;;=3^Vasomotor Rhinitis
 ;;^UTILITY(U,$J,358.3,40894,1,4,0)
 ;;=4^J30.0
 ;;^UTILITY(U,$J,358.3,40894,2)
 ;;=^5008201
 ;;^UTILITY(U,$J,358.3,40895,0)
 ;;=K05.00^^159^1995^2
 ;;^UTILITY(U,$J,358.3,40895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40895,1,3,0)
 ;;=3^Acute Gingivitis,Plaque Induced
 ;;^UTILITY(U,$J,358.3,40895,1,4,0)
 ;;=4^K05.00
 ;;^UTILITY(U,$J,358.3,40895,2)
 ;;=^334192
 ;;^UTILITY(U,$J,358.3,40896,0)
 ;;=R04.0^^159^1995^17
 ;;^UTILITY(U,$J,358.3,40896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40896,1,3,0)
 ;;=3^Epistaxis
 ;;^UTILITY(U,$J,358.3,40896,1,4,0)
 ;;=4^R04.0
 ;;^UTILITY(U,$J,358.3,40896,2)
 ;;=^5019173
 ;;^UTILITY(U,$J,358.3,40897,0)
 ;;=R09.82^^159^1995^21
 ;;^UTILITY(U,$J,358.3,40897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40897,1,3,0)
 ;;=3^Postnasal Drip
 ;;^UTILITY(U,$J,358.3,40897,1,4,0)
 ;;=4^R09.82
 ;;^UTILITY(U,$J,358.3,40897,2)
 ;;=^97058
 ;;^UTILITY(U,$J,358.3,40898,0)
 ;;=K12.30^^159^1995^20
 ;;^UTILITY(U,$J,358.3,40898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40898,1,3,0)
 ;;=3^Oral Mucositis,Unspec
 ;;^UTILITY(U,$J,358.3,40898,1,4,0)
 ;;=4^K12.30
 ;;^UTILITY(U,$J,358.3,40898,2)
 ;;=^5008486
 ;;^UTILITY(U,$J,358.3,40899,0)
 ;;=J30.1^^159^1995^10
 ;;^UTILITY(U,$J,358.3,40899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40899,1,3,0)
 ;;=3^Allergic Rhinitis d/t Pollen
 ;;^UTILITY(U,$J,358.3,40899,1,4,0)
 ;;=4^J30.1
 ;;^UTILITY(U,$J,358.3,40899,2)
 ;;=^269906
 ;;^UTILITY(U,$J,358.3,40900,0)
 ;;=R09.81^^159^1995^18
 ;;^UTILITY(U,$J,358.3,40900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40900,1,3,0)
 ;;=3^Nasal Congestion
 ;;^UTILITY(U,$J,358.3,40900,1,4,0)
 ;;=4^R09.81
 ;;^UTILITY(U,$J,358.3,40900,2)
 ;;=^5019203
 ;;^UTILITY(U,$J,358.3,40901,0)
 ;;=I69.928^^159^1995^22
 ;;^UTILITY(U,$J,358.3,40901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40901,1,3,0)
 ;;=3^Speech/Lang Deficit Following Cerebvasc Disease
